• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS ELECSYS TESTOSTERONE II IMMUNOASSAY; RADIOIMMUNOASSAY, TESTOSTERONES AND DIHYDROTESTOSTERONE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS ELECSYS TESTOSTERONE II IMMUNOASSAY; RADIOIMMUNOASSAY, TESTOSTERONES AND DIHYDROTESTOSTERONE Back to Search Results
Catalog Number ASKU
Device Problem High Test Results (2457)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 12/17/2015
Event Type  malfunction  
Manufacturer Narrative
This event occurred in (b)(6).
 
Event Description
The customer reported that the values obtained with a roche instrument for one sample tested for the following tests did not fit the clinical picture of the patient: testosterone (testo), dehydroepiandrosterone sulfate (dhea-s), antibodies to tsh receptor (anti-tshr), free triiodothyronine (ft3), free thyroxine (ft4), and thyrotropin (tsh).Testo, dhea-s, anti-tshr, ft3, and ft4 values were said to be very high.The tsh value was said to be normal.The sample was tested for anti-tpo and anti-thyroglobulin using the liaison testing method and the results for these tests were positive.The sample was also tested for androstanediol glucuronide and androstenedione using a ria testing method and results from these tests were normal.The results obtained with the roche methods and other methods were said to not fit with each other.All results were sent to the physician.The customer also mentioned that another sample was collected from the patient in the same year and tested for the same tests using the roche method at a different laboratory and these results were similar to the sample in question.No specific result values were provided for any of the questioned samples.This medwatch will cover testo.Refer to the medwatches with patient identifier (b)(6) for information related to ft3, patient identifier (b)(6) for information related to ft4, patient identifier (b)(6) for information related to tsh, patient identifier (b)(6) for information related to dhea-s, and patient identifier (b)(6) for information related to anti-tshr.The patient was not adversely affected.The analyzer model and serial number used for testing was asked for, but not provided.
 
Manufacturer Narrative
The customer has provided the patient data.Including relevant test data.Data was provided for samples from the same patient tested on (b)(6) 2013, (b)(6) 2015, and for the complained sample tested on (b)(6) 2015.In the attachment, the ft3 test is referred to as "t3 libre", ft4 is referred to as "t4 libre", anti-tshr is referred to as "anti-thyroglobuline", testo is referred to as "testosterone totale", and dhea-s is referred to as "dhea sulfate".
 
Manufacturer Narrative
The customer provided data for a new sample that was tested from the patient on 01/28/2016.The sample was said to have similar values to previous samples.(b)(4).In the attachment, the ft3 test is referred to as "t3 libre", ft4 is referred to as "t4 libre", anti-tshr is referred to as "anti-thyroglobuline", testo is referred to as "testosterone totale", and dhea-s is referred to as "dhea sulfate".The patient was not suffering from a known renal insufficiency, a known liver insufficiency, or a known malignant disease.The patient was not pregnant.(b)(4).
 
Manufacturer Narrative
A sample from the patient was provided for investigation.Investigation of the sample determined that it contains an interfering factor to streptavidin.This interfering factor caused the result difference seen with the testosterone assay.This limitation is covered in product labeling.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ELECSYS TESTOSTERONE II IMMUNOASSAY
Type of Device
RADIOIMMUNOASSAY, TESTOSTERONES AND DIHYDROTESTOSTERONE
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
Manufacturer (Section G)
ROCHE DIAGNOSTICS GMBH
sandhoferstrasse 116
na
mannheim (baden-wurttemberg) 68305
GM   68305
Manufacturer Contact
michael leslie
9115 hague road
na
indianapolis, IN 46250
3175214343
MDR Report Key5355219
MDR Text Key35494536
Report Number1823260-2016-00019
Device Sequence Number1
Product Code CDZ
Combination Product (y/n)N
Reporter Country CodeBE
PMA/PMN Number
K093421
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Reporter Occupation Physician
Type of Report Initial,Followup,Followup,Followup
Report Date 03/17/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/08/2016
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberASKU
Device Lot NumberASKU
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Date Manufacturer Received12/21/2015
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage N
Patient Sequence Number1
Patient Age33 YR
-
-